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Are low tolerable upper intake levels for vitamin A
undermining eﬀective food fortiﬁcation eﬀorts?
Klaus Kraemer, Monika Waelti, Saskia de Pee, Regina Moench-Pfanner, John N Hathcock,
Martin W Bloem, and Richard D Semba
Vitamin A deﬁciency (VAD) is a major health problem, particularly in low-resource
countries, putting an estimated 125–130 million preschool-aged children at
increased risk of morbidity and mortality from infectious diseases. Vitamin A
supplementation reduces VAD and increases child survival; it is complemented by
fortifying foods with vitamin A. Concern over increased risk of bone fracture
associatedwith vitamin A intakes below the tolerable upper intake level (UL) among
populations in aﬄuent countries conﬂicts with the need to increase intakes in less
developed countries, where populations are at greater risk of VAD and intakes are
unlikely to reach the UL as diets include fewer foods containing retinol while
vitamin A from carotenoids poses no risk of overdose. With the implementation of
recently developed risk management tools, vitamin A can be used safely in food
fortiﬁcation, including point-of-use fortiﬁcation in the context of supplementation
among speciﬁc target groups in low-resource countries.
© 2008 International Life Sciences Institute
INTRODUCTION
Vitamin A deﬁciency is a major cause of morbidity, mor-
tality and blindness in the developing world, aﬀecting an
estimated 125–130 million preschool-aged children and
7 million pregnant women in low-income countries.1 An
estimated 350,000 vitamin A-deﬁcient children become
blind every year,2 and about half of them die within a
year of becoming blind. The World Health Organization
(WHO) estimated in 1995 that 3 million preschool chil-
dren throughout the world present ocular signs of
vitamin A deﬁciency and 254 million preschool children
had mild-to-moderate vitamin A deﬁciency, indicated by
low serum retinol levels.3 The prevalence of low serum
retinol levels among children under the age of 5 years in
various regions of the developing world ranged from
15% to 60% at the end of the 1990s, with Latin America,
the Eastern Mediterranean, and Western Paciﬁc at the
low end of this range, and Africa and Southeast Asia at
the high end.1,3 The impact of mild-to-moderate vitamin
A deﬁciency on children’s resistance to infectious dis-
eases has been recognized but not fully captured in sta-
tistical reports; hence, the magnitude of the vitamin A
problem may be underestimated. Vitamin A deﬁciency
not only causes night blindness in pregnant and lactating
women, it also contributes to maternal mortality and
other poor health outcomes.4 The recent 2005–2006
National Family Health Survey (NFHS-3) in India indi-
cates that vitamin A deﬁciency is still a signiﬁcant public
health problem in the wider population, as about 9% of
Indian women had night blindness during their recent
pregnancy.5
Vitamin A supplementation reduces morbidity and
mortality among preschool children in developing coun-
tries.6 The scaling up of vitamin A supplementation has
made progress over the last decade but is still not
reaching all vulnerable children with the desired dose.7,8
High-dose vitamin A supplementation is one of the most
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cost-eﬀective health interventions in developing coun-
tries. Fortiﬁcation of foods with vitamin A is a comple-
mentary approach applying a valid technology to combat
vitamin A deﬁciency where existing food supplies do not
provide adequate amounts of the nutrient.9 In doses of
200,000 IU (60 mg) of preformed vitamin A per child
only transient undesirable eﬀects (such as nausea) have
been reported in a few cases, and the long-term protec-
tion against the severe pathologies related to vitamin A
deﬁciency clearly outweighs such minimal risk. The dif-
ﬁculty of distribution at the community level, not the
adverse eﬀect, is the primary constraint on the use of
high-dose vitamin A supplementation.
For safety considerations, combined continuous
intakes from fortiﬁcation and supplementation should
not exceed the tolerable upper intake level (UL) which is
deﬁned as the highest level of daily intake that is likely
to pose no risk of adverse health eﬀects in almost all
individuals. The UL is not pertinent to the intermittent
high-dose vitamin A supplementation used in some
intervention programs.
Recently, as reviewed by Penniston and Tanumi-
hardjo,10 new concerns about the safety of vitamin A
intake have arisen from population observations in
Western countries, suggesting an association between pre-
formed vitamin A (retinol) intakes below 3,000 mg/day,
the UL for adults, and increased risk of bone fracture.
Therefore, the UK Expert Group on Vitamins and
Minerals (EVM) has decided to assign a guidance level for
long-term intake of vitamin A of 1,500 mg/day,11,12 which
is less than two times the recommended nutrient intake
(RNI) of 800 mg/day for pregnant women. Table 1 pro-
vides an overview of ULs as well as RNIs and estimated
average requirements (EARs) for vitaminA intake (mg/d).
Following the recommendations of the UN Food and
Agricultural Organization (FAO) andWHO, estimates of
vitamin A requirements are expressed as “retinol equiva-
lents” (REs), where 1 mg RE = 1 mg of retinol = 6 mg of
b-carotene = 12 mg of other carotenoids with provitamin
A activity = 3.33 IU of vitamin A activity from retinol. In
contrast, the US Food and Nutrition Board recently con-
cluded that the bioconversion of provitamin A caro-
tenoids from plants is only half the previously assumed
level, which led to the new designation of retinol activity
equivalent, or RAE.13
The purpose of this paper is to review the safety of
vitamin A in food fortiﬁcation, including multiple food
fortiﬁcation, and in targeted high-dose vitamin A supple-
mentation. It is not meant to be a systematic review of all
the evidence; rather, it is designed to highlight issues for
further discussion. It also aims to document recent devel-
opments in risk management with regard to vitamin A.
CHRONIC HIGH VITAMIN A INTAKES
Chronic hypervitaminosis A is relatively rare. It is,
however, a potential concern with any vitamin A fortiﬁ-
cation program. The manifestations of chronic hypervi-
taminosis A are varied and non-speciﬁc, and include
central nervous system eﬀects, skin disorders, conjunc-
tivitis, nausea, vomiting, teratogenicity, and hepatotoxic-
ity in adults.11,13,14 In infants and young children, skeletal
and intracranial (e.g., transient bulging fontanelle) abnor-
malities are of particular concern.13
Table 1 Tolerable ULs with criteria for derivation, RNIs, and EARs (calculated from RNIs) for vitamin A intake
recommended byWHO/FAO.
Group Criterion for UL NOAEL or LOAEL
(mg retinol/d)
Uncertainty
factor
UL RNI
(mg RAE/d)
EAR
(mg RAE/d)
<1 y Bulging fontanelle,
other symptons
6,000 10 600
1–3 y Extrapolated from adults 600 400 286
4–6 y 450 321
4–8 y Extrapolated from adults 900
9–13 y Extrapolated from adults 1,700
14–18 y, male Extrapolated from adults 2,800
14–18 y, female Teratogenicity 4,200 1.5 2,800
14–50 y, female Teratogenicity 4,500 1.5 3,000
19–50 y, female 500 357
Pregnant women,
second trimester
800 571
Lactating women
0–3 months
850 607
19–50 y, male 600 429
Other adults Liver toxicity 14,000 5 3,000
Abbreviations: EAR, estimated average requirements; LOAEL, lowest observed adverse eﬀect level; NOAEL, no observed adverse eﬀect
level; RAE, retinol activity equivalents; RNI, recommended nutrient intakes.
Data compiled from Allen et al. (2006)4 and Allen and Haskell (2002).37
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Bone abnormalities
Several studies in industrialized countries have suggested
an association exists between chronic higher intakes
of preformed vitamin A and bone fracture risk15–18 or
reduced bone mass in humans.16,19 However, the relation-
ship between vitamin A intake and bone fracture risk has
been inconsistent, as several other studies have failed to
show any such associations.20–27 Although the adverse
eﬀects of toxic doses of vitamin A on bone fragility in
animals have been established (as reviewed by Hathcock
et al.28), studies suggesting such an eﬀect in humans were
retrospective and observational; since they did not
involve the extremely high intakes used in animal studies,
their results must be interpreted with caution. Most
human studies were not speciﬁcally designed to examine
the relationship between retinol intake and bone health.12
Some studies used plasma retinol or fasting serum retinyl
esters as biomarkers for vitamin A intake, although
fasting serum retinyl esters do not correlate with total
vitamin A intake.29 They may reﬂect recent excess intake
rather than long-term intake. In addition, dietary assess-
ment methods used in most studies were inadequate for
obtaining reliable estimates of total vitamin A intake.
Retinol is found in high concentrations in a limited
number of foods (e.g., liver), that are consumed infre-
quently by most populations. Thus, dietary assessment of
preformed vitamin A intake can result in high inter- and
intra-individual variance and reliable individual estima-
tion requires either long-term assessment (>20 d)30 or a
semi-quantitative food frequency questionnaire.31 In the
only available randomized clinical trial, short-term high
vitamin A supply (7,500 mg/day over 6 weeks) did not
aﬀect bone turnover in men.32 Although very high doses
of vitamin A clearly aﬀect bone adversely (as reviewed by
Dary and Mora9), it is still not clear whether those detri-
mental eﬀects occur at usual intakes, such as <3,000 mg
retinol/day.
b-carotene
b-carotene and other pro-vitamin A carotenoids have no
vitamin A toxicity.9,33 This may explain why no increased
risk of bone fracture has been observed with high levels
of b-carotene intake15,16,21,26,27 or in association with high
b-carotene serum levels.17 However, prolonged high-
level intake of b-carotene may cause carotenodermia, a
yellow-orange discoloration of the skin, which is harm-
less and without other consequences. Two clinical trials
reported an increase in lung cancer in heavy tobacco
smokers and asbestos workers associated with daily
b-carotene supplements of 30 mg and 20 mg, respec-
tively, but these doses are much higher than those nor-
mally available in the diet.34,35
SETTING TOLERABLE U INTAKE LEVELS
Tolerable upper intake levels are set to protect the popu-
lation from adverse health eﬀects. They are derived from
NOAELs (no observed adverse eﬀect levels) or, if these
are not available, from LOAELs (lowest observed adverse
eﬀect levels) by applying uncertainty factors.13 A UL is
only set with an identiﬁed hazard and typically when
dose-response data is available; it is thus considered to
protect virtually 100% of the population.36 A transient
increase above the UL is considered as safe for most
people because of the built-in generous safety margin.
Table 1 provides an overview of ULs for retinol
intake (mg/day) and the criteria upon which they are
based. The US Food and Nutrition Board based the UL
for women of reproductive age on teratogenicity and for
all other adults on liver abnormabilities.13 Based on pos-
sible birth defects as a critical safety issue, the US Food
and Nutrition Board identiﬁed a NOAEL of 4,500 mg/day
from food and supplements, and applied an uncertainty
factor of 1.5 to arrive at a UL of 3,000 mg/day for women
of reproductive age. In order to deﬁne a UL for men, a
LOAEL of 14,000 mg/day for hepatotoxicity and an uncer-
tainty factor of 5 were applied to arrive at a UL of
3,000 mg/day. The US Food and Nutrition Board judged
that the conﬂicting results from the studies on bone frac-
ture risk were not useful for setting a UL for retinol. To
derive a UL for infants (aged 0–12 months), case reports
of hypervitaminosis in infants were used. A LOAEL of
6,460 mg/day was identiﬁed and an uncertainty factor of
10 was applied to arrive at a UL of 600 mg/day. Due to
limited case report data of hypervitaminosis A in children
and adolescents, the UL values for them were extrapo-
lated from those established for adults on the basis of
relative body weight.
The EU Scientiﬁc Committee on Food (SCF) iden-
tiﬁed the following LOAELs: 7,500 mg/day for hepatotox-
icity, 3,000 mg/day for teratogenicity and, tentatively,
1,500 mg/day for bone density/fracture.14 These diﬀer
from those of the US Food and Nutrition Board.13 The
adverse eﬀects on bone health were reported at lower
daily intakes than the other eﬀects. However, the EU
Scientiﬁc Committee on Food considered that the data
on fracture risk provided insuﬃcient evidence and were
not appropriate for establishing a UL. Therefore, the UL
for adults has been set at 3,000 mg/day from foods and
supplements, based on the LOAEL for teratogenicity.
Post-menopausal women are advised to restrict their
intake to 1,500 mg/day because of a possible higher risk
of osteoporosis. The UL values for infants and children
were extrapolated from the value of 3,000 mg/day for
adults, with correction for diﬀerences in basal metabolic
rate using scaling according to body surface area (body
weight0.75).
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The UK Expert Group on Vitamins and Minerals
decided there was insuﬃcient evidence to set a “safe
upper level”, therefore a “guidance level” of 1,500 mg RE
(correctly, RE in the form of retinol/day) was estab-
lished.11,12 As with the US Food and Nutrition Board and
the EU Scientiﬁc Committee on Food, they judged it
prudent to take 3,000 mg/day as the threshold for terato-
genicity. The risk of hip fracture, in contrast, is a continu-
ous, graded response associated with exposure levels that
include average dietary intakes. Thus, they judged that
total intakes of >1,500 mg/day may be inappropriate.
Nevertheless, because of overlap with reasonable dietary
intakes, a change in dietary advice to all consumers was
not justiﬁed.12 No guidance level was set for children.11
VITAMIN A INTAKE IN INDUSTRIALIZED AND
DEVELOPING COUNTRIES
Natural sources of vitamin A include retinol and retinyl
esters from animal products and provitamin A caro-
tenoids (mainly b-carotene) from fruits, vegetables, and
oils. Consumption of natural sources of vitamin A rarely
results in toxicity, with the exception of excessive and
continued consumption of liver over a long period of
time.37
Industrialized countries
Vitamin A intake can be relatively high in speciﬁc
segments of the population. The UK National Diet and
Nutrition Survey (NDNS) for adults aged 19–64 years
found that the diet of 9% of men and 4% of women
include retinol at levels above 1,500 mg/day.38 Liver and
supplements (including ﬁsh liver oil) were the major
sources for those with retinol intakes >1,500 mg/day, con-
tributing 70% and 16–17% of total retinol intake, respec-
tively. In the United States, about 25% of preschool
children exceed the UL of 600 mg/day from foods, but
remain below the LOAEL of 6,000 mg/d.37 In non-
pregnant and non-lactating women aged 19–30 years in
the United States, however, the 99th percentile of retinol
intake from food alone does not exceed the UL. Cases
with clinical signs of vitamin A deﬁciency are rare but do
occur in marginalized populations and need due atten-
tion (personal communication: Richard Semba).
In developed countries, several foods are being for-
tiﬁed with vitamin A. Important food vehicles include
margarine, breakfast cereals, and milk.37 The increased
consumption of fortiﬁed foods and dietary supplements
containing vitamin A may result in a larger percentage
of the population with vitamin A intakes higher than
recommended.37 This may not, however, guarantee an
adequate supply of vitamin A in all population groups,
particularly in vulnerable groups, such as pregnant and
lactating women. Health advice discourages pregnant
women from consuming food sources rich in vitamin A,
i.e., liver and some types of ﬁsh.39,40 Recently, concern was
raised about low vitamin A status in new mothers of
high-to-moderate socioeconomic backgrounds in
Germany.41 Accordingly, mothers and their oﬀspring of
lower socioeconomic status may be at even greater risk.
Developing countries
Risk factors for vitamin A deﬁciency in developing coun-
tries include low dietary intakes of preformed vitamin A
from dairy products, liver, eggs, and fortiﬁed foods.
Vitamin A intake in developing countries mostly consists
of provitaminA carotenoids from fruits and vegetables as
vitamin A from animal sources is commonly not aﬀord-
able for the poor. Hence, dietary diversiﬁcation is
regarded as inadequate for controlling vitamin A deﬁ-
ciency.42 The presence of infections such as measles,
diarrheal diseases and helminth infections also contribute
to vitamin A deﬁciency.6 Recently, the US Food and
Nutrition Board concluded that the bioeﬃcacy of provi-
tamin A carotenoids of plant origin is only half of what
was previously assumed.13 Studies in developing coun-
tries estimate that 21 mg of b-carotene from a typical
mixed plant-based diet of vegetables and fruits, 26 mg of
b-carotene from green leafy vegetables or 12 mg of
b-carotene from fruits yield 1 mg RAE. At these conver-
sion rates, it is impossible for young children to consume
suﬃcient quantities of vegetables and seasonal fruits to
meet the RNIs or Recommended Dietary Allowances
(RDAs). Moreover, most developing areas of the world
neither produce nor consume adequate amounts of pro-
vitamin A-rich plants.43
There is limited information on the contribution of
fortiﬁed foods to total dietary vitamin A intake in devel-
oping countries. Fortiﬁed foods have been shown to con-
tribute substantially to vitamin A intake in children, to
improve vitamin A status and to reduce the vitamin
A-related anemia burden.44,45 Data from Guatemala indi-
cate that in the 1990s a maximum of 600 mg of vitamin
A/daymay have come from fortiﬁed foods.44 Preschoolers
who consumed fortiﬁed foods in addition to a diet that
contained vitamin A-rich foods may have temporarily
exceeded the UL of 600 mg/day, but this would have been
well below the LOAEL of 6,000 mg of retinol. About 40%
of Indonesian children aged 11–23 months obtained at
least one-third of their RNI for vitamin A from retinol-
rich animal-derived and fortiﬁed foods; the 95th percen-
tile from all sources amounted to 500 mg/day.46 Data were
collected between 1999 and 2001 among urban dwellers
having access to vitamin A-fortiﬁed foods (e.g., dry milk,
instant noodles, complementary foods, and infant
formula).
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FOOD FORTIFICATION AND POINT-OF-USE
FORTIFICATION IN THE CONTEXT OF
SUPPLEMENTATION
In recent years, mass fortiﬁcation with vitamin A has
becomemore frequent in developing countries. The most
common food vehicles for vitamin A fortiﬁcation include
sugar, margarine, vegetable oils, cereal ﬂours, milk, and
instant noodles.4,47
Excessive retinol exposure from a single source in
developing country settings is unlikely. However, con-
cerns about inadvertent excessive retinol intakes have
arisen due to overly frequent periodic supplementation
combined with concurrent use of multiple micronutrient
supplements, point-of-use fortiﬁcation with micronutri-
ent powders, fortiﬁed staple foods, as well as voluntarily
fortiﬁed commercial foods.
Periodic supplementation with high-dose vitamin A
capsules is the approach commonly used for controlling
vitamin A deﬁciency and reducing related morbidity and
mortality among children aged 6–59 months in develop-
ing countries. Many countries also have policies to
provide high-dose vitamin A capsules to women shortly
after delivery. Over the last decade, progress has been
made in eﬀorts to increase the coverage of vitamin A
supplementation programs, but these programs are still
not reaching all vulnerable children with the desired
dose.8 In 2004, just 58% of all children under the age of
5 years received two doses of vitaminA per year. In 2005–
2006, on average, only 18% of Indian children under the
age of 5 years received a vitamin A supplement in the
6 months prior to the national survey.5
High-dose vitamin A supplements are used for pro-
phylaxis in breast-feeding women and young children.
TheWHO and the International Vitamin A Consultative
Group currently recommend two doses of 200,000 IU
vitamin A administered at least 24 hours apart within 6
weeks after delivery to the mothers; their infants should
receive 50,000 IU at 6, 10, and 14 weeks.42,48 Between 6
and 11 months of age, a single dose of 100,000 IU is
recommended, followed by 200,000 IU every 4–6 months
between the ages of 12 and 59 months. However, in the
Philippines, the prevalence of vitamin A deﬁciency
(serum retinol <0.7 mmol/L) among children under 5
years rose from 35.8% to 38% between 1993 and 1998
despite a comprehensive biannual vitamin A capsule dis-
tribution program.49 Moreover, the eﬀect of the supple-
mentation on serum retinol persisted in most areas and
periods for only 1–2 months, rather than the recom-
mended 6 months between doses.
Among malnourished children, only 30–50% of a
high-dose supplement is retained.6 Even the administra-
tion of 200,000 IU vitaminAmonthly between the ages of
12 and 24 months is likely to be safe, with only mild,
transient, adverse eﬀects. Only in the highly unlikely situ-
ation that a child’s catabolic rate is close to that of an adult
and the child receives 200,000 IU monthly between 12
and 24 months of age will liver vitamin A concentrations
exceed the proposed cut-oﬀ of 300 mg/g.37 Hence, it
appears likely that there is no risk from two high-dose
vitaminA supplements per year given to a child under the
age of 5 years in the context of concurrent fortiﬁcation or
point-of-use fortiﬁcation programs.
Periodic high-dose vitaminA supplementation alone
is inadequate to address vitamin A deﬁciency (see discus-
sion on vitamin A intake above). Low coverage with
vitamin A supplementation due to lack of supplements
and poor compliance, low absorption rate, and the bioki-
netics of single high-dose vitaminA supplements point to
the need for additional approaches to meet the vitamin A
requirements of target groups. Moreover, other popula-
tion groups that are potentially at risk of vitamin A deﬁ-
ciency are excluded from supplementation programs.
Dietary diversiﬁcation is regarded as inadequate to
control vitamin A deﬁciency in this respect.42 Fortiﬁca-
tion of food (mandatory and voluntary), use of low-dose
supplements, and point-of-use fortiﬁcation provide
complementary approaches and should, on a mid- to
long-term basis, replace high-dose vitaminA supplemen-
tation under developing country settings. This may
encourage increased intake of vitamin A by other high-
risk groups that are often unnecessarily excluded from
vitamin A supplementation, such as pregnant women.
MODELS FOR SAFE ADDITION OF VITAMIN A
A comparatively narrow range of safe intake is a big chal-
lenge to setting safe levels for vitamin A fortiﬁcation and
supplementation. On one hand, there is a potential risk
that some consumers may exceed the UL on a daily basis
due to the consumption of a limited number of foods
(e.g., liver and liver products); on the other, there are
signiﬁcant numbers of people at risk of insuﬃcient
intake.10 Moreover, the UK National Diet and Nutrition
Survey38 demonstrated clearly that the range of intakes
for diﬀerent age and sex groups varies widely, reﬂecting
the limited distribution of preformed vitamin A in foods,
i.e., the intake distribution of vitamin A is skewed with
median intakes typically 20–50% below mean intakes,50
indicating that a signiﬁcant proportion of the population
is at risk of inadequate intake.
To ensure that the outcome of a fortiﬁcation
program is adequate and does not lead to harmful
intakes, it is important to collect food intake data on all
types of food consumed (fortiﬁed, unfortiﬁed, and point-
of-use fortiﬁed), as well as other sources such as dietary
supplements.4 This should be supported by ﬁndings on
nutritional status, including biochemical or clinical data.
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Quantitative food and nutrient intake data should be col-
lected from diﬀerent population groups. The fortiﬁcation
guidelines of the World Health Organization deﬁne the
dietary goal of fortiﬁcation as being to provide most
(97.5%) individuals in the population group(s) at greatest
risk of deﬁciency with an adequate intake of speciﬁc
micronutrients, without causing a risk of excessive
intakes in this or other groups.4 Figure 1 depicts how a
safe range of nutrient intakes from all dietary sources and
supplements can be assembled.
The EAR cut-point method: model for mass
food fortiﬁcation
The WHO/FAO guidelines on food fortiﬁcation with
micronutrients recommend the EAR cut-point method
(Figure 2).4 This method has been proposed and
described in detail by the US Food and Nutrition Board.51
The method requires the assessment of food and nutrient
intake data in speciﬁc population subgroups, particularly
in the subgroups with the highest risk of deﬁciency and
the highest risk of excess. The EAR is used to estimate the
proportion of inadequate intake of a given nutrient in
every population subgroup. The aim is to shift the intake
distribution upwards so that only 2.5% of the target
population remains below the EAR. Knowing the intake
distribution of the chosen food vehicle also enables the
eﬀect of adding diﬀerent levels of nutrient to the food
vehicle to be simulated. This allows calculating the pro-
portion of intakes below the EAR and above the UL for
diﬀerent fortiﬁcation levels. Thus, the most appropriate
fortiﬁcation level can be identiﬁed, i.e., a level that pre-
vents deﬁciency in a population at risk, but avoids a high
proportion of very high intakes.4
Figure 1 Safe range of nutrient intakes: from all dietary sources and supplements.
Abbreviations: RDA, recommended dietary allowance; RNI, recommended nutrition intake; UL, upper limit of tolerable upper
intake level; NOAEL, no observed adverse eﬀect level; LOAEL, lowest observed adverse eﬀect level. Supplements also comprise
micronutrient powders.
Figure 2 EAR cut-point method for fortiﬁcation programs taking beneﬁt and safety into consideration. Assessment of
intake distribution among population subgroups and selection of EAR for planning of “target median intake” shows that 50%
of the population is still below the nutrient requirement, which is not acceptable; selection of RDA for planning of “target
median intake” reveals that 2.5% of population is below the RDA requirement, which increases the risk of exceeding the UL.
Therefore, the recommended planning strategy is to shift intake distribution upwards so that only 2.5% of the target popula-
tion remains below the EAR, as depicted in the ﬁgure.
Abbreviations: EAR, estimated average requirement (median); RDA, recommended dietary allowance.
Adapted from Allen et al. (2006)4 with permission from The World Health Organization, Geneva, Switzerland.
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For mass fortiﬁcation, it is common practice to use
staple foods as food vehicles. Staples are usually con-
sumed in higher quantities by adults than by children.
This is diﬀerent for market-driven fortiﬁcation. Market-
driven fortiﬁed processed foods (e.g., breakfast cereals,
beverages, nutritional bars) are usually marketed to all
family members, and the same serving size may be con-
sumed by all members of the family. Therefore, the
maximum micronutrient content per serving size needs
to be deﬁned by taking into account the UL for the most
vulnerable groups (e.g., children aged 4–8 years), the
amount of nutrients provided by the diet and fortiﬁed
foods (in the context of a concurrent mass fortiﬁcation
program involving this group), and the number of
servings per day.4
Maximummicronutrient content per kcal serving size40
15
=
− +( )UL a b
In this formula, UL represents the UL for children aged
4–8 years; a represents the amount of micronutrients
provided by diet at the 95th percentile of the 4–8-year
group; and b represents the amount of micronutrients
provided to the 4–8-year-old group by fortiﬁed foods in
the context of a concurrent mass fortiﬁcation program.
It is assumed that a maximum of 30% of an individu-
al’s daily energy intake (2,000 kcal) is derived from forti-
ﬁed processed foods. If the smallest dietary serving size is
40 kcal, the number of daily servings of children aged 4–8
years equates to at least 15.
International Life Sciences Institute Europe: model for
voluntary fortiﬁcation of processed foods
Flynn et al. 52 have developed amodel for Europe to deter-
mine the safe maximum levels of voluntary micronutri-
ent addition to foods. The maximum amount of a
nutrient that can be safely added to foods can be esti-
mated as the diﬀerence between the UL and the mean
intake of the nutrient at the 95th percentile. The model
calculates the amount of nutrient (FAn) that can be safely
added to each 100 kcal portion:
FA
UL CI
PFFn n
=
−[ ]
× ×
95
0 5 36.
In this model, UL represents the UL for adult males;
CI95 represents the intake of micronutrients from non-
fortiﬁed foods of adult males at the 95th percentile; PFFn
represents the proportion of food in the market that is
available for fortiﬁcation.
The 95th percentile of daily energy intake by adult
males in Europe is estimated to be about 3,600 kcal,
which corresponds to 36 portions of 100 kcal. Further, it
is assumed that no more than 50% of food energy is
suited for food fortiﬁcation because some foods, such as
non-processed, non-packaged or traditional foods, are
unlikely to be fortiﬁed. Other factors limiting food forti-
ﬁcation include technological, cost, organoleptic and
other constraints. In the development of the model,
intakes from supplements were not taken into account
because supplement users were considered to represent
only a minority of the population.
In Europe, the 95th percentile intake of retinol of
adult men exceeds the UL.52 Therefore, there is no need to
fortify other foods or to increase the fortiﬁcation level of
retinol in Europe. More recently, the International Life
Sciences Institute model was applied to propose maximal
levels for fortiﬁcation in the Netherlands.53
CONCLUSION
In developing countries, the most common nutritional
problem is still inadequate provision of vitaminA.Rarely,
if ever, is overly frequent dosing or vitaminA intake from
too many sources a problem. Indeed, vitamin A supple-
mentation is important to alleviate vitamin A deﬁciency.
However, it remains a short-term solution for practical
and economic reasons. In the mid- and long-term, an
integrated approach is required that combines low-dose
supplementation, food fortiﬁcation, point-of-use fortiﬁ-
cation, and promotion of locally available and culturally
acceptable vitamin A-rich foods. This will enable the
delivery of vitaminA tailored to the needs of all groups in
the population. This approach may potentially put some
individuals at risk of excessive intake but, in recent years,
models have been developed for the safe addition of
nutrients to foods. These models should be applied and
further adapted to the situations in developing countries,
where quality data on vitamin A intakes and status are
frequently lacking.
Public health nutrition interventions need to accom-
modate potential beneﬁts and risks, i.e., achieving optimal
nutrient intakes with low prevalence of both inadequate
and excessive nutrient intakes. Narrow safety margins for
nutrients betweendesired eﬀects in target populations and
potential hazards in others require that public health spe-
cialists and policy makers familiarize themselves with
simultaneous analyses of hazards and beneﬁts. Thus, an
overly cautious setting of the UL, at as low as 1,500 mg
retinol/day, would create a substantial barrier to supple-
mentation and fortiﬁcation with vitamin A in developing
countries, because it would conﬂict with an eﬃcacious
intake of the vitamin from all sources. The well-
documented and widespread problem of excessive mor-
tality andmorbidity in children andmothers as a result of
vitamin A deﬁciency in low-resource countries contrasts
sharply with the speculative and inadequately docu-
mented risk of osteoporosis in old age in industrialized
countries.
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